Evidence map›Paper›PMID 32948011›Full record

ArticleInternational journal of molecular sciences2020

Inhaled H

Viktória Kovács, Gábor Remzső, Valéria Tóth-Szűki, Viktória Varga, János Németh, Ferenc Domoki

Abstract read
In one paragraph

Article in International journal of molecular sciences, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Article
  3. Article
  4. Article
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Viktória KovácsDepartment of Physiology, University of Szeged Faculty of Medicine, H-6720 Szeged, Hungary.ORCID 0000-0001-7474-7148
Gábor RemzsőDepartment of Physiology, University of Szeged Faculty of Medicine, H-6720 Szeged, Hungary.
Valéria Tóth-SzűkiDepartment of Physiology, University of Szeged Faculty of Medicine, H-6720 Szeged, Hungary.ORCID 0000-0003-2418-4214
Viktória VargaDepartment of Physiology, University of Szeged Faculty of Medicine, H-6720 Szeged, Hungary.
János NémethDepartment of Physiology, University of Szeged Faculty of Medicine, H-6720 Szeged, Hungary.
Ferenc DomokiDepartment of Physiology, University of Szeged Faculty of Medicine, H-6720 Szeged, Hungary.

Funding

EU-funded Hungarian grant EFOP-3.6.1-16-2016-00008EU-funded Hungarian grant GINOP 2.3.2 15 2016 00034Hungarian Brain Research Program 2.0 2017-2.1 NKP 2017 00002National Research, Development and Innovation Office OTKA-PD128464
6 · The paper itself

Abstract

Hypoxic-ischemic encephalopathy (HIE) is still a major cause of neonatal death and disability as therapeutic hypothermia (TH) alone cannot afford sufficient neuroprotection. The present study investigated whether ventilation with molecular hydrogen (2.1% H

Indexed as

Hypothermia, InducedAcidosisAdministration, InhalationAnimalsAnimals, NewbornApoptosis Inducing FactorAsphyxia NeonatorumBrain Damage, ChronicBrain-Derived Neurotrophic FactorCarbon DioxideCaspase 3Caudate NucleusCerebral CortexDisease Models, AnimalDrug Evaluation, PreclinicalElectroencephalographyApoptosis Inducing FactorBrain-Derived Neurotrophic FactorCarbon DioxideCaspase 3HydrogenNerve Tissue ProteinsNeuroprotective Agentsbrain-derived neurotrophic factorhydrogen ventilationhypoxic-ischemic encephalopathyperinatal asphyxiapiglet modeltherapeutic hypothermia

Identifiers

PMID32948011
PMCPMC7555370

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.